Dear all (+ Wojtek Cellary, organisor of I3E),
I just phoned Alfred Hofmann from Springer (for I3E and for another
non-IFIP event) and got the following maybe important information:
There are two possibilities for IFIP publications:
- "old style KAP" (Kluwer Academic Publisher)
- Springer LNCS.
Apparently there is heavy competition between those two possibilities
inside the newly merged Kluwer-Springer.
It is strongly recommended by Alfred Hofmann to use LNCS instead as
of old-style KAP.
The reasons:
- LNCS is much cheaper (in the bookstore) than old-style KAP,
just 35 percent of old-style KAP;
it is soft-cover instad as of hard-cover but for only a third of
the price this appears to be more than tolerable.
- LNCS is included in digital library, old-style KAP is not.
- The organisor doesn't have to make a certain bulk size at his own risk,
he can order as many copies as he wants.
- The organisor gets 50 copies for free, thus for some small workshops
he will not have to pay a single cent for the proceedings;
the Springer revenue out of LNCS comes from the much higher
sales numbers due to the much cheaper price. Thus Springer can afford
to give 50 copies for free.
- As an example, Alfred told me that INTERACT took 450 books with
850 pages each. The cost with old-style KAP would have been
63.000 EURO (or maybe dollar, I don't remember perfectly)
but with LNCS it was not more than 19.000 EURO (or dollar).
Thus LNCS publication is very strongly recommended.
The only condition is that a very thorough and strong reviewing
will be effected.
I urge all of our WG chairs that they invite many organisors
to seriously check the LNCS possibility. Alfred told me that some other
TC's have already taken this as the standard way for publishing
IFIP event proceedings.
Alfred's phone number is in the list of IFIP delegates: +49-6221-4878599
Hofmann(a)Springer.de
Yana Lambert (from old-style KAP) will not be delighted to see that
comparison but she will have to live with it.
Best regards
Otto
Dear Otto,
Thank you very much for this information. It will be very useful for the
conferences organised in developing countries. This point, in Toulouse
during the GA, remain in the dark space, even that several question appear
to know these aspects, but Jennifer Evans (Yana Lambert was sick) skipped
to answer.
Best regards
Ramon
> Dear all (+ Wojtek Cellary, organisor of I3E),
>
> I just phoned Alfred Hofmann from Springer (for I3E and for another
> non-IFIP event) and got the following maybe important information:
>
> There are two possibilities for IFIP publications:
> - "old style KAP" (Kluwer Academic Publisher)
> - Springer LNCS.
>
> Apparently there is heavy competition between those two possibilities
> inside the newly merged Kluwer-Springer.
>
> It is strongly recommended by Alfred Hofmann to use LNCS instead as
> of old-style KAP.
>
> The reasons:
> - LNCS is much cheaper (in the bookstore) than old-style KAP,
> just 35 percent of old-style KAP;
> it is soft-cover instad as of hard-cover but for only a third of
> the price this appears to be more than tolerable.
> - LNCS is included in digital library, old-style KAP is not.
> - The organisor doesn't have to make a certain bulk size at his own risk,
> he can order as many copies as he wants.
> - The organisor gets 50 copies for free, thus for some small workshops
> he will not have to pay a single cent for the proceedings;
> the Springer revenue out of LNCS comes from the much higher
> sales numbers due to the much cheaper price. Thus Springer can afford
> to give 50 copies for free.
> - As an example, Alfred told me that INTERACT took 450 books with
> 850 pages each. The cost with old-style KAP would have been
> 63.000 EURO (or maybe dollar, I don't remember perfectly)
> but with LNCS it was not more than 19.000 EURO (or dollar).
>
> Thus LNCS publication is very strongly recommended.
> The only condition is that a very thorough and strong reviewing
> will be effected.
> I urge all of our WG chairs that they invite many organisors
> to seriously check the LNCS possibility. Alfred told me that some other
> TC's have already taken this as the standard way for publishing
> IFIP event proceedings.
>
> Alfred's phone number is in the list of IFIP delegates: +49-6221-4878599
> Hofmann(a)Springer.de
>
> Yana Lambert (from old-style KAP) will not be delighted to see that
> comparison but she will have to live with it.
>
> Best regards
> Otto
>
>
>
>
> _______________________________________________
> ifip-tc6 mailing list
> ifip-tc6(a)lists.RWTH-Aachen.DE
> http://MailMan.RWTH-Aachen.DE/mailman/listinfo/ifip-tc6
>
=========================================================================
Ramon Puigjaner
Universitat de les Illes Balears
Departament de Ciencies Matematiques i Informatica
07122 PALMA (Spain)
Phone: +34-971173288 Fax: +34-971173003
e-mail: putxi(a)uib.es
=========================================================================
Dear all,
please find enclosed the updated attendance list for meeting 2004/2.
Would the three delegates who didn't send any message
(i.e. delegates from Greece, Slovenia, and Syria)
please give at least one line of code concerning their presence
or - what appears to be much more likely - their non-attendance.
If I don't get at least this minimum message then I intend to ask IFIP GA for
a replacement very soon - since that form of missing activity cannot be
tolerated any longer.
Best regards
Otto
Dear all,
rien ne va plus ... concernant les contributions
pour les documents de la réunion TC6 2004/2 à Bangkok.
Vous pourriez adresser les choses les plus importantes
(s'il y en aurait cettes choses)
à Chutiporn Anutariya <chutiporn(a)shinawatra.ac.th>.
Cordialement
Otto
Lyman and all others that have sent their opinion,
Thank you very much for communicating your opinon in favour and against the
participation of TC6 in WCC and, in consequence, of my acceptation of
becoming TPC chair of WCC.
Best regards
Ramon
> Ramon,
>
> As you know, my feeling is that the WCC is indeed a "dinosaur," and
> it would be a waste of your time to chair the TPC. You are already
> involved in many other events and activities that are much more
> important and much more relevant than WCC! Similarly, I do not think
> that TC6 should spend any time or energy on WCC.
>
> - Lyman
>
> At 4:35 AM +0100 11/16/04, Ramon Puigjaner wrote:
> >Dear friends,
> >
> >All of you have received the message of Klaus Brunnstein, President of
> >IFIP. In this message I appear when he is talking about WCC.
> >
> >You should know that he has asked me to chair the TPC of this event.
> >Personally I do not know if the effort of well organising such a
> >"dinosaur", like the last one in Toulouse, is compensated by its results
> >both in scientific and personal exchanges aspects. However, my personal
> >involvement in Latin America actions obliges me to carefully consider
> >the proposal.
> >
> >After talking with Otto Spaniol, our chairman, my position is to accept
> >the proposal only if I have a strong support of TC6 both by the
> >organisation of some events in the next WCC and by the personal
> >involvement of TC6 members in the TPC. Otherwise I will be obliged to
> >withdraw the proposal.
> >
> >As this last time the electronic discussions are one of our main duties,
> >I would like to know your position, before or during our next meeting in
> >order to give me the inputs to take the correct decision.
> >
> >I wish to thank you in advance your help in clarifying my ideas.
> >
> >Best regards
> >
> >Ramon
> >=========================================================================
> >Ramon Puigjaner
> >Universitat de les Illes Balears
> >Departament de Ciencies Matematiques i Informatica
> >07122 PALMA (Spain)
> >Phone: +34-971173288 Fax: +34-971173003
> >e-mail: putxi(a)uib.es
> >=========================================================================
=========================================================================
Ramon Puigjaner
Universitat de les Illes Balears
Departament de Ciencies Matematiques i Informatica
07122 PALMA (Spain)
Phone: +34-971173288 Fax: +34-971173003
e-mail: putxi(a)uib.es
=========================================================================
Dearr all,
our meeting 2004/2 attendance is shrinking; just 14 delegates are left
(if they all show up).
Please communicate to me your view on the IFIP/IEEE case.
Answers received thus far may be classified in two parts:
- The Americans are in favour of IEEE
(the copyright issue seems to be of no impoortance for them,
at least nbody has said a single word about that aspect)
- The Americans are more on the IFIP side.
They say e.g. "Do you think that there should be only
one organisation world-wide? There is need for more".
============================================
Tissue Engineering & Stem Cell Research 2005
12th and 13th January 2005
Marriot Kensington Hotel, London
============================================
**** CONFERENCE BROCHURE AVAILABLE NOW - REQUEST YOURS TODAY ****
Visiongain Conferences are please to announce their next conference within
the pharmaceutical sector; 'Tissue Engineering & Stem Cell Research 2005'.
Stem cell therapy offers an opportunity to treat many degenerative diseases
caused by the premature death or malfunction of specific cell types and the
body's failure to replace or restore them. This conference will cover the
main disease areas where progress in stem cell research is taking place
along with a huge emphasis on regional regulatory issues.
THEMES WILL INCLUDE:
**Identify new routes to enter the market
**Discover key market segments and profit from emerging trends in stem cell
therapies
**An update on stem cell therapies: CASE STUDIES on treating- spinal cord
injuries, kidney disease,
gastrointestinal cancers, neurological diseases, myocardial and tooth
regeneration
**Analyse manufacturing practices and learn how to overcome the challenges
in tissue engineering
**Become up-to-date on regulatory issues: a global and US perspective
**Business Development: commercialisation for drug discovery and cell
therapy
KEY SPEAKERS
**Dr. Jane Lebkowski, Senior Vice President, Regenerative Medicine, Geron
**Julie Gruber Allickson, Technical Director - Laboratory Operations,
Cryo-Cell International
**Dr. Stephen Minger, Scientific Director/ Director of the Stem Cell Biology
Laboratory, CereStem Ltd/ KCL
**Dr. Christopher Bravery, Senior Scientist/Team Leader, Intercytex Limited
**Larry Soler, Vice President of Government Relations, Juvenile Diabetes
Research Foundation International
**Dr. Sara Patel, Head of NeuroImaging Group, ReNeuron
**Dr. Karl Willert, Postdoctoral fellow, Stanford University Medical Center
**Dr Phil Bates, Lecturer in Medical Law, Centre for Medical Law and Ethics,
Kings College London
**Dr Chris Potten, Chairman, Epistem
**David Hill, Scientific Director, Lawson Health Research Institute
**Dr. Lior Gepstein, Head Cardiovascular Research Laboratory,
Technion-Israel Institute of Technology
**Professor Paul Sharpe, Head of Craniofacial Development, Odontis Ltd /
King's College London
**Professor Jon Dobson,Professor of Biophysics & Biomedical Engineering ,
Keele University
**Professor Alicia El Haj, Institute of Science & Technology in Medicine,
Keele University
**Dr. Richard France, Project Manager, RegenTec Ltd
**Professor Harry Moore, Director/ Centre for Stem Cell Biology, Axordia/
University of Sheffield
------------------
WHO SHOULD ATTEND
------------------
**Senior Vice President, Regenerative Medicine
**Research Director for Assisted Reproduction and Embryonic Stem Cells
**Vice President, Technology
**Vice President, Therapeutic Development Operations
**Director, Experimental Medicine
**Vice President of Government Relations
**Vice President Clinical Affairs, & Director
**Vice President, Product Development
**Business Development Manager
---------------------
DELEGATE REGISTRATION
---------------------
Places at this event are strictly limited so BOOK YOUR PLACE NOW.
To make a booking on this event, please contact me via phone or email. Book
early to secure a place.
- PRICING -
Attend the:
2 Day conference - ONLY GBP1299 plus VAT
- BOOKINGS -
Booking is easy, simply contact me:
Andrew Oliver
Sales Manager - Conference Division
Visiongain B2B Conferences
Tel. +44(0)20 8767 6711
Fax. +44(0)20 8767 5001
mailto:andrew.oliver@visiongaingroup.com
www.b2b-conferences.com
B2B Conferences is part of the Visiongain Group
**** FULL CONFERENCE AGENDA BELOW ****
====================================
Day One Wednesday 12th January 2005
====================================
09:00 Registration and coffee
09:30 Opening remarks from the chair
AN UPDATE ON STEM CELL THERAPIES
09:40 CASE STUDY: Advances in Stem Cell Programs- Treating
Spinal Cord Injuries
How to penetrate the emerging field of regenerative medicine
Oligodendrocyte progenitors- can they restore normal neural
function?
- results in animal models: significant functional improvements
Progress in phase I clinical trials: focus on treatment for acute
spinal cord injury
Technologies in this field- licenses and intellectual property
Dr. Jane Lebkowski, Senior Vice President, Regenerative Medicine
Geron
10:20 CASE STUDY: Metanephroi Transplantation- Treating
Kidney Disease
How to develop normal renal structures by transplanting kidney
precursors
Transplanting between species without rejection- how to ensure
minimal immunosupression, leading to success
Conclusions: implanted metanephroi have intrinsic ability to
continue developing and organising into functional tissue
structures
Advantages over renal transplant or dialysis:
- better clinical outcome than intermittent dialysis, as filtration
is continuous and active
- unlimited supply of organs available by this procedure
Dr. Christopher Bravery, Senior Scientist/Team Leader
Intercytex Limited
11:00 Morning Coffee
11:20 CASE STUDY: in vitro and in vivo Model Systems- Treating
Gastrointestinal Cancers
in vivo models: using the in situ tumour model ADENOQUANT
to directly compare tumour and normal tissue responses and
assess therapeutic index
Transgenic and xenograft models: how to determine the
importance of gene pathways and treatment response in
GI tissue
in vitro screening assay: PRIMEQUANT to realistically predict
the in vivo response and allow accurate comparisons of normal
and matched tumour tissue biology
How to use assays to assess stem cell regulatory effects to
hyper- and hypoplasia therapies, wound healing agents and
mucositis therapies
Professor Chris Potten, Chairman
Epistem
12:00 CASE STUDY: Development of islets from precursor cells
in vitro and in vivo
Generation of insulin-producing cells from embryonic stem cells
or hematopoeitic stem cells
Trans-differentiation capabilities of other pancreatic cell types
to islets
Barriers to clinical application
Mechanisms of regeneration of islets in vivo
David Hill, Scientific Director
Lawson Health Research Institute
12:40 Lunch
14:00 Can Human Brain Cell Transplantation treat Neurological
Diseases?
Assess advantages and disadvantages of immortalised stem
cell lines
c-Myc gene cell lines: transplant strategies
Graft effects in animal models of neurodegenerative diseasefunctional
and structural integration
How to use stem cells as a platform technology for drug
discovery
- identifying small molecules or proteins to mature a brain stem
cell into a differentiated cell
- stem cells for screening potential lead compounds for toxicity
Dr. Sara Patel, Head of NeuroImaging Group
ReNeuron
14:40 Myocardial Regeneration Strategies using Human
Embryonic Stem Cells
Heart cells from human embryonic stem cells- progress to date
- derivation, in vitro differentiation and implications for basic
research & clinical applications
How to use it- development and testing of new drugs, genetic
studies, engineering tissues, organ transplantation, study
purposes
Myocardial regeneration strategies- replacing the dysfunctional
myocardium with new contractile tissue
Regulations in Israel- looking to the future in research
Dr. Lior Gepstein, Head Cardiovascular Research Laboratory
Technion-Israel Institute of Technology
15:20 Afternoon Tea
15:40 CASE STUDY: Regenerative Dentistry- How to Grow a
Tooth
How to understand and genetically control the key processes
forming teeth in the embryo
Interactions between epithelial and mesenchymal cells
- how to culture cells to form primordia
Results from mice populations- tooth rudiments formed from in
vitro cultures of non-dental stem cell populations
Can rudiments be transferred to adults? - formation of
complete teeth and associated bones
Professor Paul Sharpe, Head of Craniofacial Development
Odontis Ltd / King's College London
MANUFACTURING PRACTICES: CHALLENGES IN TISSUE ENGINEERING
16:20 Implications of GTP/GMP for Cord Blood Processing
Moving from Clean Lab to an ISO class 7 Cleanroom
Environment
How the FDA's proposed GTP affects cell processing
Future Direction: cord blood processing - regulatory impacts
Julie Gruber Allickson, Technical Director - Laboratory Operations
Cryo-Cell International
17:00 Questions and Discussion
17:10 Chairman Summation
17:20 Close of Conference
===================================
Day Two Thursday 13th January 2005
===================================
09:00 Registration and coffee
09:30 Opening remarks from the chair
An Overview of the Industry
The panel session at the end of Day Two will offer you the chance
to hear from Ray Scraggs, Head Consultant at visiongain on the
most detailed and accurate market information available on Tissue
Engineering and Stem Cell Research.
09:40 Advances in Tissue Regeneration: Human ES Cells,
Growth Factors and Biotherapeutic Molecules
The sources of stem cell and ES cells- learn about the benefits
of stem cell technology
Cell nuclear replacement: the fight against type 1 diabetes and
Parkinson's disease
Exploiting novel growth factors: promoting the proliferation and
lineage-specific propagation of stem cell populations
Dr. Stephen Minger, Scientific Director/ Director of the Stem Cell Biology
Laboratory
CereStem Ltd/ King's College London
10:20 Magnecell's Mechanical Conditioning Bioreactor
Systems: How to Activate Ion Channels
Update on ex-vivo bone engineering results
- speed of matrix mineralisation; regulation of genes involved
in bone growth
Patent technologies for tissue engineering: mechanisms for
ex-vivo simulation of the in-vivo stress environment
Applications of system: drug screening, in-vitro testing and
stem cell research
Future areas for growth: ex-vivo magnetic activation of in-vivo
cellular processes
Professor Jon Dobson,
Professor of Biophysics & Biomedical Engineering/ Co-Founder
and Technical Advisor
Keele University/ Magnecell Limited
11:00 Morning Coffee
11:20 Biodegradable scaffolds - Delivery systems for Cell
Therapies
Osteochondral and corneal repair using cell therapies and
tissue engineering approaches
Delivery vehicles and biodegradable scaffolds for cell therapies
Scaffold design and in vitro and in vivo tissue engineering
strategies
Stem Cell targeting
Professor Alicia El Haj, Institute of Science & Technology in Medicine
Keele University
12:00 Self Assembling and Injectable Materials for
Regenerative Medicine
Injectable biodegradable scaffolds for cell and growth factor
delivery
Crosslinking strategies for scaffold self assembly
Controlling macroporosity within the scaffold environment
Dr. Richard France, Project Manager
RegenTec Ltd
12:40 Lunch
14:00 Stem Cell Maintenance: Results from Isolating the Wnts
Protein
Potential of isolating Wnt proteins- can stem cells be used
for bone marrow transplants?
Wnt signaling: a common theme in animal development
How do Wnt proteins cause hematopoietic stem cells to divide?
Analysis: pathways triggering stem cell growth
Dr. Karl Willert, Postdoctoral Fellow
Stanford University Medical Center
REGULATORY ISSUES
14:40 Global Perspective: Legal Framework for Stem Cell
Research
Global situation: US Federal ban on all bar 60 stem cell lineseffects
on federally-funded research and privately funded
research
What is the legal framework for research in the UK?
Lack of a co-ordinated global policy: effects on research
Better results from stem cells derived from bone marrow
and the placenta than embryonic stem cells
Dr Phil Bates, Lecturer in Medical Law
Centre for Medical Law and Ethics
Kings College London
15:20 Afternoon Tea
15:40 Regulation in the US: Expanding the Current Federal
Policy on Stem Cell Research
The "Stem Cell Research Enhancement Act of 2004"
Problems with the existing policy and proposed changes
to overcome them
Is adult stem cell research a feasible alternative?
California's Proposition 71- update on progress
Slowing down research- JDRF perspective
Larry Soler, Vice President of Government Relations
Juvenile Diabetes Research Foundation International
BUSINESS DEVELOPMENT
16:20 Human Embryonic Stem Cells: Commercialisation for
Drug Discovery and Cell Therapy
Cell lines and quality assurance
the challenge of generating GMP ES cell lines
Regulating proliferation and plurioptency
Markers of differentiation
Production platforms
Professor Harry Moore, Director/ Centre for Stem Cell Biology
Axordia/ University of Sheffield
17:00 Discussion: Attendees Perspective
Presentation and discussion by Dr. Ray Scraggs of the previous
days questionnaire results. An insight will be given into the
market revenues, growth areas, new developments and new
entrants to the Tissue Engineering and Stem Cell Research
industry. This will involve some freeform discussion giving you
the opportunity to engage in knowledge-sharing with fellow
professionals
Moderator: Dr. Ray Scraggs, Head Consultant
visiongain Consultancy
17:20 Question and Discussion
17:30 Chairman Summation
17:30 Close of Conference
Terms & Conditions
NB - Due to high demand, we do not 'reserve' or 'hold' places - a request
for an invoice to be raised will be treated as an official booking and will
be subject to the cancellation policy as outlined below.
Cancellations/substitutions and name changes: All bookings carry a 50%
liability after the booking has been made, by post fax, email or web. There
will be no refunds for cancellations received on or after one month before
the start of the conference (e.g. cancellation on or after 20th January for
a conference starting on 20th February). If you decide to cancel after this
date the full invoice remains payable. Conference notes, which are available
on the day, will be sent to you. Unfortunately we are not able to transfer
places between conferences and executive briefings. However if you are
unable to attend the event you may make a substitution/name change at any
time as long as we are informed in writing by e-mail, fax or post. Name
changes and substitutions must be from the same company and are not
transferable between companies or countries.
Indemnity: visiongain Ltd reserve the right to change the
conference/executive briefing content, timing, speakers or venue without
notice. The event may be postponed or cancelled due to acts of terrorism,
war, extreme weather conditions, industrial action, acts of God or any event
beyond the control of visiongain Ltd. If such a situation arises we will
endeavour to reschedule the event. However, visiongain Ltd cannot be held
responsible for any cost, damage or expenses, which may be incurred by the
customer as a consequence of the event being postponed or cancelled. We
therefore strongly advise all customers to take out insurance to cover the
cost of the registration, travel and expenses.
To unsubscribe please reply with unsubscribe in the subject line.
Data protection: Visiongain Ltd gathers and manages data in accordance with
the Data Protection Act 1998. Information contained about you may be used to
update you on visiongain Ltd products and services via post, telephone, fax
or email, unless you state otherwise. If you wish your details to be
amended, please send your request to the Database Manager, visiongain Ltd,
40 Tooting High Street, London, SW17 0RG. Alternatively please reply with
unsubscribe in the subject line. Please allow approximately 7 days for your
removal or update request, you may receive additional pieces of
communication from visiongain Ltd during the transitional period, whilst the
changes come into effect.
Dear friends,
All of you have received the message of Klaus Brunnstein, President of
IFIP. In this message I appear when he is talking about WCC.
You should know that he has asked me to chair the TPC of this event.
Personally I do not know if the effort of well organising such a
“dinosaur”, like the last one in Toulouse, is compensated by its results
both in scientific and personal exchanges aspects. However, my personal
involvement in Latin America actions obliges me to carefully consider
the proposal.
After talking with Otto Spaniol, our chairman, my position is to accept
the proposal only if I have a strong support of TC6 both by the
organisation of some events in the next WCC and by the personal
involvement of TC6 members in the TPC. Otherwise I will be obliged to
withdraw the proposal.
As this last time the electronic discussions are one of our main duties,
I would like to know your position, before or during our next meeting in
order to give me the inputs to take the correct decision.
I wish to thank you in advance your help in clarifying my ideas.
Best regards
Ramon
=========================================================================
Ramon Puigjaner
Universitat de les Illes Balears
Departament de Ciencies Matematiques i Informatica
07122 PALMA (Spain)
Phone: +34-971173288 Fax: +34-971173003
e-mail: putxi(a)uib.es
=========================================================================
4th Mediterranean Workshop on Ad-Hoc Networks
MED-HOC-NET 2005
Ile de Porquerolles, June 21-24, 2005
First Call for papers
The fourth Med-Hoc-Net 2005 is a major annual international workshop in
the Mediterrnean
region. It brings together researchers, technologists and visionaries
from academia, research
labs, and industry, engineers and students to exchange, discuss and
share their experiences,
new ideas and research about theoretical and practical aspects of ad-hoc
networking.
Med-Hoc-Net 2005 will include presentations of theoretical and
experimental achievements, innovative ad-hoc systems, prototyping
efforts, case studies, and advancements in technology directly
affecting ad-hoc networking and communications infrastructures.
The papers solicited in Med-Hoc-Net 2005 cover a variety of topics
including but not limited to:
- Implementations, testbeds, and prototypes,
- Performance evaluation of ad-hoc network protocols through simulations,
analysis, and measurements,
- Metrology, Ad-Hoc network measurement Tools,
- MAC protocols, scheduling, and radio resource sharing in ad hoc
networks,
- Power management and control,
- Topology control,
- Self-organization and network reconfiguration,
- Unicast and multicast routing algorithms and protocols,
- Energy-efficient communications in ad-hoc networks,
- Transport layer protocols for multi-hop networks,
- Resource discovery and management,
- Protocols for QoS support in ad-hoc networks,
- Call admission and traffic shaping policies for ad-hoc networks,
- Multimedia location services,
- Security in ad-hoc networks,
- Fault tolerance and error recovery
- Algorithmic challenges in ad-hoc networks,
- Large scale ad-hoc networks ,
- Interconnection between ad hoc and wired networks,
- Sensor networks: applications and protocols.
After Sardinia (Italy), Mahdia (Tunisia) and Bodrum (Turkey), this
year the workshop will take place in another beautiful spot on the
Mediterranean Sea: Ile de Porquerolles (France).
Steering Committee: Farouk Kamoun (ENSI, Tunisia)
Mario Gerla (UCLA, USA)
Guy Pujolle (LIP6, France)
Khaldoun Al Agha (LRI, France)
Giovanni Pau (UCLA, USA)
Conference Chairs: Khaldoun Al Agha (LRI, University of Paris XI) and Guy
Pujolle (LIP6, University of Paris VI)
Program Chair: Isabelle Guérin Lassous (INRIA, France)
Proceedings chair : Erwan ERMEL (LIP6/France)
Organization Chair :Davor MALES (LIP6, France)
Webmaster : GAWDESKI Ignacy (LRI, France)
Program Committee:
Ian F. AKYILDIZ (Georgia Institute of Technology, USA)
Khaldoun AL AGHA (LRI, France)
Christian BECKER (University of Stuttgart, Germany)
Brahim BENSAOU (Hong Kong University of science and technology, Hong Kong)
Andrew T. CAMPBELL (Columbia University, USA)
E. CAYIRCI (Istanbul Technical University, Turkey)
Andrea CLEMENTI (University Roma II, Italy)
Marco CONTI (CNR, Italy)
Silvia GIORDANO (University of Applied Science, Switzerland)
Stephen HAILES (University College London, United Kingdom)
Farouk KAMOUN (ENSI, Tunisia)
P. R. KUMAR (University of Illinois, Urbana-Champaign, USA)
Pascale MINET (INRIA, France)
Sotiris NIKOLETSEAS (CTI/Univ. of Patras, Greece)
Giovanni PAU (UCLA, USA)
Guy PUJOLLE (LIP6, France)
Laurent REYNAUD (FT R&D, France)
Christian PREHOFER (DoCoMo Euro-Labs, Germany)
David SYMPLOT-RYL (University of Lille, France)
Isabela SIQUEIRA (Federal University of Minas Gerais, Brazil)
Stavros TOUMPIS ( Vienna Telecommunications Research Center, Austria)
Christian TSCHUDIN (University of Basel, Switzerland)
Guillaume VIVIER (Motorola, France)
Stefan WEBER (Trinity College Dublin, Ireland)
Vincent W.S. WONG (University of British Columbia, Canada)
Hiroyuki YOMO (Aalborg University, Danemark)
Authors are invited to submit electronically original contributions in
the conference themes
and related topics. Papers should not be longer than 12 pages. All
submitted papers will be
reviewed and evaluated on the basis of relevance, originality, technical
quality and clarity.
Accepted papers will be included in the conference proceedings. The
official workshop oral
and written language is English.
Paper Submission Deadlines
Full Paper Electronic Submission : 11 March 2005
Notification of acceptance/Rejection : 15 April 2005
Camera ready submission of full papers: 13 May 2005
